---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-105155"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2024-09-10T23:59:59+00:00"
generated_at: "2026-05-31T05:36:53.059401+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Heart Test Laboratories enters $2.51M note purchase agreement with Streeterville Capital, net proceeds $1.86M

## Summary
- Issued $2.51M unsecured promissory note to Streeterville Capital; 8.5% interest, 18-month maturity, $500K OID.
- Net proceeds of $1.86M after OID and $10K transaction expenses; used for general working capital.
- Monthly redemption cap of $270K starting March 2025; balance increases 5% if not reduced by $900K by Sept 2025.
- Placement agents Maxim Group and Ascendiant Capital received 7% commission on gross proceeds.
- Note sold in unregistered transaction relying on Section 4(2) exemption; HSCS listed on Nasdaq.

## SEC filing metadata
- accession: 0000950170-24-105155
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2024-09-10T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017024105155/0000950170-24-105155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017024105155/hscs-20240906.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-105155
- JSON: https://secwatch.observer/filing/0000950170-24-105155.json
- Plain text: https://secwatch.observer/filing/0000950170-24-105155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.